Class information for:
Level 1: FAS//FAS LIGAND//FASL

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1319 2720 41.9 92%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
441 3       TRAIL//SURVIVIN//APOPTOSIS 26474
306 2             TRAIL//SURVIVIN//APOPTOSIS 18497
1319 1                   FAS//FAS LIGAND//FASL 2720

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 FAS authKW 1239214 19% 21% 529
2 FAS LIGAND authKW 989290 11% 30% 292
3 FASL authKW 431718 5% 27% 142
4 CD95 authKW 400449 5% 25% 145
5 SOLUBLE FAS authKW 288268 2% 55% 47
6 FAS ANTIGEN authKW 146094 2% 30% 43
7 APO 1 authKW 116400 1% 45% 23
8 SOLUBLE FAS LIGAND authKW 116400 1% 45% 23
9 CD95 LIGAND authKW 113398 1% 42% 24
10 FAS APO 1 CD95 authKW 95767 1% 53% 16

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Immunology 10382 30% 0% 826
2 Oncology 4827 23% 0% 629
3 Cell Biology 2311 16% 0% 448
4 Hematology 1523 8% 0% 216
5 Medicine, Research & Experimental 1383 9% 0% 257
6 Biochemistry & Molecular Biology 633 17% 0% 458
7 Pathology 554 5% 0% 128
8 Transplantation 510 3% 0% 88
9 Gastroenterology & Hepatology 219 4% 0% 96
10 Genetics & Heredity 131 4% 0% 119

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INTERNAL MED MOL CYTOL 35917 0% 80% 4
2 TUMOR IMMUNOL PROGRAM 35195 1% 10% 31
3 IMMUNOGENET G0300 25253 0% 75% 3
4 CANCEROL MOL 22449 0% 100% 2
5 COMPOSANTES INNEES REPONSE IMMUNITAIRE DIFF 22449 0% 100% 2
6 LEAH EDWARD M FRANKEL BONE MARROW TRANSPLAN 22449 0% 100% 2
7 DEV MOL TARGET DRUGS 18927 0% 19% 9
8 MOL BIOL DIS 14961 0% 33% 4
9 TUMORIMMUNOL PROGRAM 12210 0% 16% 7
10 FRANKEL 11690 0% 15% 7

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CELL DEATH AND DIFFERENTIATION 9515 2% 2% 52
2 JOURNAL OF IMMUNOLOGY 7044 7% 0% 186
3 EUROPEAN JOURNAL OF IMMUNOLOGY 4203 3% 1% 71
4 INTERNATIONAL IMMUNOLOGY 3565 1% 1% 36
5 CELLULAR IMMUNOLOGY 2469 2% 1% 42
6 PEZCOLLER FOUNDATION SYMPOSIA 1973 1% 1% 19
7 JOURNAL OF EXPERIMENTAL MEDICINE 1863 2% 0% 46
8 BLOOD 1275 2% 0% 65
9 IMMUNITY 1148 1% 1% 19
10 NATURE MEDICINE 981 1% 1% 18

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 FAS 1239214 19% 21% 529 Search FAS Search FAS
2 FAS LIGAND 989290 11% 30% 292 Search FAS+LIGAND Search FAS+LIGAND
3 FASL 431718 5% 27% 142 Search FASL Search FASL
4 CD95 400449 5% 25% 145 Search CD95 Search CD95
5 SOLUBLE FAS 288268 2% 55% 47 Search SOLUBLE+FAS Search SOLUBLE+FAS
6 FAS ANTIGEN 146094 2% 30% 43 Search FAS+ANTIGEN Search FAS+ANTIGEN
7 APO 1 116400 1% 45% 23 Search APO+1 Search APO+1
8 SOLUBLE FAS LIGAND 116400 1% 45% 23 Search SOLUBLE+FAS+LIGAND Search SOLUBLE+FAS+LIGAND
9 CD95 LIGAND 113398 1% 42% 24 Search CD95+LIGAND Search CD95+LIGAND
10 FAS APO 1 CD95 95767 1% 53% 16 Search FAS+APO+1+CD95 Search FAS+APO+1+CD95

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 PETER, ME , HADJI, A , MURMANN, AE , BROCKWAY, S , PUTZBACH, W , PATTANAYAK, A , CEPPI, P , (2015) THE ROLE OF CD95 AND CD95 LIGAND IN CANCER.CELL DEATH AND DIFFERENTIATION. VOL. 22. ISSUE 4. P. 549 -559 113 65% 14
2 NAGATA, S , GOLSTEIN, P , (1995) THE FAS DEATH FACTOR.SCIENCE. VOL. 267. ISSUE 5203. P. 1449-1456 64 49% 3499
3 EHRENSCHWENDER, M , WAJANT, H , (2009) THE ROLE OF FASL AND FAS IN HEALTH AND DISEASE.THERAPEUTIC TARGETS OF THE TNF SUPERFAMILY. VOL. 647. ISSUE . P. 64-93 134 47% 31
4 DE LA ROSA, AJ , GOMEZ, MA , MORALES, S , PADILLO, FJ , MUNTANE, J , (2014) CD95 SIGNALING IN CANCER TREATMENT.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 17. P. 2809 -2818 97 55% 1
5 IGNEY, FH , KRAMMER, PH , (2005) TUMOR COUNTERATTACK: FACT OR FICTION?.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 54. ISSUE 11. P. 1127-1136 75 82% 49
6 MAGGI, CA , (1998) THERAPEUTIC OPPORTUNITIES FROM THE PHARMACOLOGICAL MANIPULATION OF THE FAS SYSTEM.PHARMACOLOGICAL RESEARCH. VOL. 38. ISSUE 1. P. 1 -34 150 54% 9
7 ZHAO, HG , MAO, WM , CHEN, WH , DU, P , QIN, JF , ZHUANG, CY , TONG, JL , WANG, LF , (2016) FASL-844T/C MUTATION MAY PARTICIPATE IN OCCURRENCE AND DEVELOPMENT OF PULMONARY SQUAMOUS CELL CARCINOMA IN SOUTH CHINA.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. VOL. 9. ISSUE 2. P. 4263 -4272 53 93% 0
8 MUSCHEN, M , WARSKULAT, U , BECKMANN, MW , (2000) DEFINING CD95 AS A TUMOR SUPPRESSOR GENE.JOURNAL OF MOLECULAR MEDICINE-JMM. VOL. 78. ISSUE 6. P. 312-325 86 75% 102
9 HOOGWATER, FJH , STELLER, EJA , WESTENDORP, BF , RINKES, IHMB , KRANENBURG, O , (2012) CD95 SIGNALING IN COLORECTAL CANCER.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1826. ISSUE 1. P. 189 -198 85 59% 8
10 NAGATA, S , (1999) FAS LIGAND-INDUCED APOPTOSIS.ANNUAL REVIEW OF GENETICS. VOL. 33. ISSUE . P. 29 -55 89 49% 516

Classes with closest relation at Level 1


Rank Class id link
1 23365 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME//ALPS UNIT//DN T CELLS
2 14699 C FLIP//FADD//DEATH EFFECTOR DOMAIN
3 26875 APO 1 ANTIBODY//APO I FAS APOPTOSIS//APOPTOSIS CYTOKINES
4 37441 CHEM BIOKATALYSIS//FAS LIGANDFASL CD95 L//FLOW CYTOMETRIC ANALYSIS FCA
5 24860 BRICHOS DOMAIN MUTATIONS//VA PUGET SOUND MED//ALLERGY INFECT MED
6 25218 ORAL BIOL ORAL MED//CD3 ZETA//ZETA CHAIN
7 28260 CASP8 652 6N DEL//CASPASE8//CASP8
8 1157 TRAIL//DR5//TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND
9 1845 APAF 1//CASPASE 2//CASPASE
10 5991 NEW ZEALAND MICE//RHEUMATOL CLIN MED//MURINE LUPUS

Go to start page